This bill allows New Jersey healthcare providers to prescribe Schedule II controlled substances, such as certain pain medications, through telemedicine without requiring an in-person examination. It permits these prescriptions based on a remote provider-patient relationship, provided the provider has reviewed the patient's medical records and determined they can meet the standard of care remotely. The legislation also mandates that providers disclose their credentials, offer patients the option to see a physician specifically, and ensure proper follow-up care is arranged. By amending existing state laws, the bill expands access to specific controlled medications for patients using virtual healthcare services while maintaining regulatory oversight.
This bill requires healthcare platforms in New Jersey to advise and consult with consumers regarding the therapeutic values, hazards, and uses of drugs, biologicals, and devices they send. The law mandates that these platforms provide this information using electronic methods such as email, text messaging, or video calls. It directly affects online services that allow members to obtain discounts on medications or access telemedicine services. The legislation clarifies that these platforms must follow existing pharmacy practice standards when communicating with users about their prescriptions and medical devices.
This bill mandates that all students in grades six through twelve in New Jersey public and nonpublic schools undergo a specific physical examination that includes a cardiac component. To ensure this requirement is met, the physical must be performed by a licensed healthcare professional who has completed specialized training to recognize signs of heart disease and abnormalities. Schools are required to keep a signed form from the provider confirming that this specific training was completed before the student can participate in school activities. The law takes effect immediately and applies to the 2023-2024 school year, expanding upon existing rules that already require similar exams for student athletes.
This bill requires New Jersey's Department of Health to monitor and evaluate hospitals for compliance with federal rules on price transparency. The state agency will use methods such as reviewing complaints and auditing hospital websites to check if facilities are properly displaying their standard charges online. If a hospital is found noncompliant, the department can issue warnings, demand a corrective action plan, or impose civil monetary penalties that will be published on the department's website. Additionally, the department must publish an annual report detailing these compliance findings and any recommendations for the Governor and Legislature.
This bill creates the Targeted Midwifery Workforce Development Act to address racial disparities in maternal and infant health outcomes in New Jersey. It allocates $12 million to expand training and support for midwives, aiming to increase access to culturally competent care for Black communities who currently face higher risks of pregnancy-related death and infant mortality. The legislation directly affects healthcare providers, educational institutions, and state agencies involved in workforce development and maternal health services. By investing in midwifery education and addressing systemic inequities, the bill seeks to improve birth outcomes and reduce the gap between Black and white residents in the state.
This New Jersey Assembly resolution urges the federal government to pass a bill that would remove waiting periods for disability benefits and Medicare for people with young-onset Alzheimer's diagnosed before age 65. The proposed federal law aims to eliminate the current 29-month delay in Medicaid coverage, ensuring these individuals receive medical support immediately upon diagnosis. By addressing bureaucratic delays, the legislation seeks to provide timely access to care for approximately 200,000 Americans affected by the disease and their families.
This bill creates the Kidney Disease Study Commission within New Jersey's Department of Health to investigate kidney disease research. The nine-member commission will include state officials and six public members appointed by legislative and executive leaders to oversee studies on disease causes, treatment patterns, and transplant rates, with a specific focus on minority and underserved populations. The commission will hold public hearings, utilize state staff for support, and submit annual reports to the Governor and Legislature detailing its findings and recommendations.
This bill requires NJ FamilyCare to cover prescriptions for healthy foods for certain enrollees, aiming to improve nutrition access for people with diet-related health conditions. It defines a "food prescription" as a healthcare provider's written order for specific foods to treat conditions like obesity or diabetes. The legislation also establishes a fund and program to support small food retailers and pharmacies in low and moderate-income areas to stock and sell fresh produce and other healthy items at affordable prices. By integrating healthy food prescriptions into the state's Medicaid program, the bill seeks to help residents in underserved communities gain better access to nutritious options.
This bill expands a pilot program into a statewide initiative, requiring the Office of the Public Defender to implement a team-based representation model across all regional offices. Under this new system, each client receives a team consisting of a staff attorney and a non-attorney client services specialist who work together to address both legal issues and underlying personal challenges. The client services specialist is tasked with connecting individuals to resources for mental health, substance abuse treatment, housing, employment, and other social needs while the attorney focuses on legal defense. By integrating social support directly into the legal process, the bill aims to provide more comprehensive assistance to people involved in the criminal justice system.
This bill creates a statewide "Zero Suicide" initiative within New Jersey's Department of Health to help healthcare facilities and behavioral health providers prevent suicide through evidence-based practices. The program will offer voluntary training, technical assistance, and certification for organizations that adopt specific safety protocols, such as risk screening and continuity of care plans. To support these efforts, the legislation allows for grants to certified providers and establishes a framework for enhanced Medicaid reimbursement incentives. Ultimately, the act aims to integrate suicide prevention into routine clinical care while recognizing and rewarding facilities that successfully implement these standards.